Speakers
Distinguished Panel and Speakers include:
- Professor Dame Julia Polak, Founder/Director, NovaThera & Imperial College, UK
- Dr Kwan Hee Lee, Chief Executive Officer, TissueGene, USA
- Dr Robert Preti, President and Chief Scientific Officer, Progenitor Cell Therapy, USA
- Dr Brian A. Meltzer, Senior Director, Venture Program Management, Johnson & Johnson Corporate Development, USA
- Dr Tim Allsopp, Chief Scientific Officer, Stem Cell Sciences, UK
- Dr Edward Field, President & Chief Operating Officer, Aldagen, Inc., USA
- Dr Andrew Pecora, Chairman, Amorcyte, USA
- Dr Markus Jerling, Chief Medical Officer, NeuroNova AB, Sweden
- Dr Robin Quirk, Co-Founder and Chief Operating Officer, RegenTec, UK
- Dr Stewart Craig, Principal, Broken Lance Biotechnology Consulting, USA
- Dr Robert Deans, Senior Vice-President of Regenerative Medicine, Athersys, USA
- Dr Raimund Strehl, Head of Development, Cellartis AB, Sweden
- Mr George Schlich, Partner, Schlich & Co, Chartered Patent Agents, UK
- Dr Amir Toren, Director of Business Development, Pluristem Therapeutics, Israel
- Dr Sonya Faber, Business Development Manager, Fraunhofer Institute, Germany